These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36335745)
1. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum. Wang Y; Li Y; Chen J; Liu H; Zhou Y; Huang C; Liang L; Liu Y; Wang X J Inorg Biochem; 2023 Jan; 238():112054. PubMed ID: 36335745 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway. Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878 [TBL] [Abstract][Full Text] [Related]
3. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells. Yuan Y; Zhang Y; Chen J; Huang C; Liu H; Li W; Liang L; Wang Y; Liu Y Eur J Med Chem; 2023 Feb; 247():115046. PubMed ID: 36577214 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways. Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750 [TBL] [Abstract][Full Text] [Related]
6. Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis. Zhang H; Liao X; Wu X; Shi C; Zhang Y; Yuan Y; Li W; Wang J; Liu Y J Inorg Biochem; 2022 Mar; 228():111706. PubMed ID: 35033830 [TBL] [Abstract][Full Text] [Related]
7. Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo. Zhou Y; Bai L; Tian L; Yang L; Zhang H; Zhang Y; Hao J; Gu Y; Liu Y J Inorg Biochem; 2021 Oct; 223():111550. PubMed ID: 34311319 [TBL] [Abstract][Full Text] [Related]
8. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation. Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells. Xie B; Wang Y; Wang D; Xue X; Nie Y Molecules; 2022 Aug; 27(17):. PubMed ID: 36080200 [TBL] [Abstract][Full Text] [Related]
10. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes. Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887 [TBL] [Abstract][Full Text] [Related]
11. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria. Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300 [TBL] [Abstract][Full Text] [Related]
12. Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway. Chen J; Liu H; Chen Y; Hu H; Huang C; Wang Y; Liang L; Liu Y J Inorg Biochem; 2023 Apr; 241():112145. PubMed ID: 36709684 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells. Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro. Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032 [TBL] [Abstract][Full Text] [Related]
15. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis. Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973 [TBL] [Abstract][Full Text] [Related]
16. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells. Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells. Chen Y; Gu Y; Hu H; Liu H; Li W; Huang C; Chen J; Liang L; Liu Y J Inorg Biochem; 2023 Apr; 241():112134. PubMed ID: 36706490 [TBL] [Abstract][Full Text] [Related]
18. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway. Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria. Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986 [TBL] [Abstract][Full Text] [Related]
20. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells. Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]